Short answer: Some kinds of AI work should be paused or restricted, but a blanket pause on all AI would likely do more harm than good. The pragmatic path is targeted, conditional restrictions on specific high‑risk capabilities, with clear criteria for lifting them, while allowing low‑risk and beneficial R&D to proceed.
How to decide what to pause or restrict
•Focus on dangerous capabilities, not brand names:
•Bio-risk enablement (designing pathogens or bypassing lab safety)
•Advanced cyber-offense (zero‑day discovery/exploitation)
•Scalable manipulation (high-fidelity personalized persuasion at scale)
•Autonomous replication or access to critical infrastructure
•Use capability evaluations and red‑teaming to classify models/use cases into tiers (green/yellow/red) and gate deployment accordingly.
When a pause is warranted
•There is plausible risk of large-scale, irreversible harm.
•Safeguards, monitoring, or response capacity are clearly insufficient.
•Independent evaluators have flagged unmet risk thresholds (“circuit breaker” triggers).
•Specific examples: training or deploying models that show strong bio-design assistance or persistent autonomous tool use without robust containment.
What restrictions make sense
•Licensing for very large training runs and for operating high‑end AI compute clusters; require safety cases before training and before deployment.
•Mandatory pre‑deployment safety evaluations, third‑party audits, and incident reporting for high‑risk systems.
•Compute governance: report and log large training runs; hardware/firmware attestation; cloud‑level throttles for flagged workloads.
•Deployment controls: rate limits, tool‑use sandboxes, geofencing, identity verification for access to sensitive capabilities, content provenance/watermarking, and rollback plans.
•Data governance: strict controls on high‑risk datasets (e.g., pathogen protocols, exploit kits), and privacy safeguards.
•Use‑case rules: forbid or tightly regulate AI control of critical infrastructure and lethal autonomous functions.
Why not a blanket pause
•Enforceability is low and could shift development to opaque actors/jurisdictions.
•It would delay clear benefits (health, accessibility, climate, productivity) and entrench incumbents.
•Targeted guardrails can reduce risk while preserving innovation.
What to allow and accelerate
•Safety science: interpretability, robustness, alignment techniques, evaluations, secure tooling.
•Social-good applications with demonstrably low risk, under normal product safety and privacy laws.
•Open research with risk‑aware release practices (staged access, model distillations without dangerous tools, delayed weights).
Concrete next steps
•Policymakers:
•Define capability-based tiers and publish evaluation protocols.
•Require licensing and audits above compute/capability thresholds; mandate incident reporting.
•Fund independent testbeds, red‑team consortia, and talent for oversight.
•Harmonize internationally on chip/export controls and cloud reporting; enable cross‑border audit cooperation.
•Developers/labs:
•Adopt safety cases, gated rollouts, continuous monitoring, and kill‑switches.
•Log training data lineage; restrict dangerous tools; offer researcher access for audits.
•Run and publish standardized evals; participate in shared red‑teaming.
•Enterprises/end‑users:
•Perform DPIAs/impact assessments; keep humans in the loop for consequential decisions.
•Track model updates, regressions, and incidents; set escalation paths.
•Civil society/academia:
•Independent evaluations, whistleblower channels, and participatory oversight to keep governance grounded in public interest.
Bottom line: Don’t pause AI across the board. Do impose conditional pauses and strict restrictions on clearly dangerous capabilities until safety, security, and accountability criteria are met—and keep those criteria measurable, auditable, and tied to concrete capability thresholds. If you want, I can sketch a one‑page policy for a specific sector or for the U.S. context.